MIM
ONCE

Macroview Investment Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Macroview Investment Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-38
Closed -$3K – 379
2018
Q2 		$3K Buy
+38
New +$2.93K 0.01% 236

Other funds holding ONCE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Macroview Investment Management's ONCE Position: Q3 2018 in Review

Macroview Investment Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2018, closing a stake of 38 shares — an estimated $3K sold.

Macroview Investment Management first reported a position in ONCE in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 176 funds tracked by Wall St. Rank hold ONCE as of Q3 2018.

  • Macroview Investment Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Macroview Investment Management sold 38 Spark Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $3K.
  • Macroview Investment Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Macroview Investment Management's Spark Therapeutics, Inc. Common Stock position peaked at $3K in Q2 2018.
  • 176 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2018.

Based on Macroview Investment Management's 13F filing for Q3 2018, filed 2 Nov 2018.